JUN 21, 2018 9:00 AM PDT

Can AI Beat Cancer?

Speaker
  • Founder and Chairman at Cancer Commons
    Biography
      Dr. Jay M. ("Marty") Tenenbaum, a world-renowned Internet commerce pioneer and visionary, founded CommerceNet (1994) to accelerate business use of the Internet. While at CommerceNet, he co-founded Veo Systems (1997), the company that pioneered the use of XML for automating business-to-business transactions. When Commerce One acquired Veo Systems in January 1999, Dr. Tenenbaum became chief scientist and was instrumental in shaping the company's business and technology strategies for the Global Trading Web.

      Post Commerce One, Dr. Tenenbaum was an officer and director of Webify Solutions (sold to IBM in 2006) and Medstory (sold to Microsoft in 2007). Currently, his focus is on transforming healthcare and accelerating therapy development through collaborative e-science. Towards that end, he founded CollabRx, which builds "virtual biotechs" to help slash the time, cost, and risk of developing new therapies."

      Prior to CommerceNet, he was founder and CEO of Enterprise Integration Technologies, the first company to conduct a commercial Internet transaction (1992), secure Web transaction (1993), and Internet auction (1993). Earlier in his career, Dr. Tenenbaum was also a prominent AI researcher, and led AI research groups at SRI International and Schlumberger Ltd.

      Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former consulting professor of Computer Science at Stanford. He currently serves as a director of Efficient Finance, Patients Like Me, and the Public Library of Science, and is a consulting professor of Information Technology at Carnegie Mellon's new West coast campus.

      Dr. Tenenbaum holds B.S. and M.S. degrees in Electrical Engineering from MIT, and a Ph.D. from Stanford.

    Abstract

    Finding effective treatments for cancer is fundamentally  a high-dimensional probabilistic planning, search, and optimization problem, characterized by  thousands of molecular subtypes,  tens of thousands of plausible drug regimens, and a dearth of high quality data on clinical responses.  These explosive combinatorics and the lack of data are overwhelming traditional approaches to clinical development, including the latest Bayesian adaptive trial designs and big data analytics.  However, this is precisely the kind of knowledge-based  planning and search problem that AI is uniquely designed to solve.  Many organizations are developing relevant AI-based applications, from decision support and treatment planning to treatment validation and real time response monitoring.  We will review these developments and describe a bold industry-wide initiative to integrate them for the immediate benefit of all cancer patients and their physicians, while radically improving the efficiency of clinical research and drug development. 


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    JUN 21, 2018 9:00 AM PDT

    Can AI Beat Cancer?


    Specialty

    Cancer Diagnostics

    Cancer Research

    Cancer

    Clinical Diagnostics

    Big Data

    Biomarkers

    Tumor

    Earth Science

    Flow Cytometry

    University

    Immuno-Oncology

    Vaccine Research

    Gene Expression

    Dna

    Mass Cytometry

    Geography

    North America33%

    Asia33%

    Europe33%

    Registration Source

    Website Visitors100%

    Job Title

    Student33%

    Research Scientist33%

    Medical Laboratory Technician33%

    Organization

    Hospital33%

    Manufacturer - Other33%

    Academic Institution33%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more